|
CH621479A5
(US06252093-20010626-C00008.png)
*
|
1977-08-05 |
1981-02-13 |
Battelle Memorial Institute |
|
|
IT1110989B
(it)
*
|
1979-01-19 |
1986-01-13 |
Erba Farmitalia |
Forme farmaceutiche costitutite da liposomi e procedimenti relativi
|
|
FR2416008A1
(fr)
*
|
1978-02-02 |
1979-08-31 |
Oreal |
Lyophilisats de liposomes
|
|
IT1111367B
(it)
*
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
|
JPS55118415A
(en)
*
|
1979-02-28 |
1980-09-11 |
Pii Papahadojiyopo Dometoriosu |
Method of encapsulating biologically active substance in lipoid cell
|
|
DE2914789A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Injizierbare arzneimittel mit entzuendungshemmender wirkung
|
|
DE2914788A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
|
JPS55153713A
(en)
*
|
1979-05-02 |
1980-11-29 |
Kureha Chem Ind Co Ltd |
Pharmaceutical preparation of ribosome containing active substance
|
|
CA1173360A
(en)
*
|
1979-06-22 |
1984-08-28 |
Jurg Schrank |
Pharmaceutical preparations
|
|
US4310505A
(en)
*
|
1979-11-08 |
1982-01-12 |
California Institute Of Technology |
Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
|
|
HU184141B
(en)
*
|
1979-12-27 |
1984-07-30 |
Human Oltoanyagtermelo |
Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
|
|
JPS5775916A
(en)
*
|
1980-10-29 |
1982-05-12 |
Nippon Chemiphar Co Ltd |
Coenzyme q pharmaceutical and its preparation
|
|
JPS57146710A
(en)
*
|
1981-03-07 |
1982-09-10 |
Kunio Yagi |
Blood brain-barrier permeating ribosome-like microcapsule
|
|
US4397846A
(en)
*
|
1981-05-15 |
1983-08-09 |
Murray Weiner |
Storage-stable lipid vesicles and method of preparation
|
|
JPS58128318A
(ja)
*
|
1982-01-22 |
1983-07-30 |
フアイソンズ・ピ−エルシ− |
薬学的組成物
|
|
JPS58222014A
(ja)
*
|
1982-06-18 |
1983-12-23 |
Taisho Pharmaceut Co Ltd |
プロスタグランジンｅ↓１脂肪乳剤
|
|
US4588578A
(en)
*
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
|
GB8322178D0
(en)
*
|
1983-08-17 |
1983-09-21 |
Sterwin Ag |
Preparing aerosol compositions
|
|
US4744989A
(en)
*
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
|
US5141674A
(en)
*
|
1984-03-08 |
1992-08-25 |
Phares Pharmaceutical Research N.V. |
Methods of preparing pro-liposome dispersions and aerosols
|
|
JPS60208910A
(ja)
*
|
1984-03-31 |
1985-10-21 |
Green Cross Corp:The |
水難溶性薬物・リン脂質複合体の製造方法
|
|
SE8403905D0
(sv)
*
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
|
US5077056A
(en)
*
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
DE3582905D1
(de)
*
|
1984-08-10 |
1991-06-27 |
Syntex Inc |
Stabile liposome mit wasserloeslichen arzneimitteln.
|
|
JPS6150912A
(ja)
*
|
1984-08-16 |
1986-03-13 |
Shionogi & Co Ltd |
リポソ−ム製剤の製造法
|
|
JPS61100518A
(ja)
*
|
1984-10-22 |
1986-05-19 |
Ono Pharmaceut Co Ltd |
ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4830858A
(en)
*
|
1985-02-11 |
1989-05-16 |
E. R. Squibb & Sons, Inc. |
Spray-drying method for preparing liposomes and products produced thereby
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
FR2591105B1
(fr)
*
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
|
US5068198A
(en)
*
|
1986-03-26 |
1991-11-26 |
Syntex (U.S.A.) Inc. |
Liquid single reagent for assays involving confining gels
|
|
SE8601457D0
(sv)
*
|
1986-04-01 |
1986-04-01 |
Draco Ab |
Compositions of liposomes and b?712-receptor active substances for inhalation
|
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
|
SE8603812D0
(sv)
*
|
1986-09-12 |
1986-09-12 |
Draco Ab |
Administration of liposomes to mammals
|
|
US4891324A
(en)
*
|
1987-01-07 |
1990-01-02 |
Syntex (U.S.A.) Inc. |
Particle with luminescer for assays
|
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
|
WO1988009170A1
(en)
*
|
1987-05-22 |
1988-12-01 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
US4981690A
(en)
*
|
1987-10-27 |
1991-01-01 |
Board Of Regents, The University Of Texas System |
Liposome-incorporated mepartricin
|
|
JPH0610131B2
(ja)
*
|
1987-10-30 |
1994-02-09 |
テルモ株式会社 |
リポソームの製法
|
|
EP0397774A1
(en)
*
|
1988-02-04 |
1990-11-22 |
Board Of Regents, The University Of Texas System |
Formulation and use of retinoids in treatment of cancer and other diseases
|
|
US5096629A
(en)
*
|
1988-08-29 |
1992-03-17 |
501 Nippon Fine Chemical Co., Ltd. |
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
|
|
ATE147633T1
(de)
*
|
1988-10-27 |
1997-02-15 |
Univ Minnesota |
Immunhilfsmittel aus liposome enthaltend lymphokin il -2
|
|
US5174988A
(en)
*
|
1989-07-27 |
1992-12-29 |
Scientific Development & Research, Inc. |
Phospholipid delivery system
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
IN172208B
(US06252093-20010626-C00008.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
DK0555229T3
(da)
*
|
1990-07-31 |
1996-08-19 |
Liposome Co Inc |
Akkumulation af aminosyrer og peptider i liposomer
|
|
US5340716A
(en)
*
|
1991-06-20 |
1994-08-23 |
Snytex (U.S.A.) Inc. |
Assay method utilizing photoactivated chemiluminescent label
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
US5885260A
(en)
*
|
1991-05-30 |
1999-03-23 |
Mehl, Sr.; Thomas L. |
Freeze-dried liposome delivery system for application of skin treatment agents
|
|
CA2110490C
(en)
*
|
1991-06-18 |
2008-07-29 |
Evan C. Unger |
Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior
|
|
FR2681781A1
(fr)
*
|
1991-09-30 |
1993-04-02 |
Oreal |
Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
|
|
EP0624095B2
(en)
*
|
1991-12-31 |
2005-07-20 |
Zymogenetics, Inc. |
Methods and compositions for reducing blood loss
|
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
USRE37224E1
(en)
*
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
US5736141A
(en)
*
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
ATE162892T1
(de)
*
|
1992-07-31 |
1998-02-15 |
Behringwerke Ag |
Photoaktivierbare chemiluminizierende matrices
|
|
DE4309579C3
(de)
*
|
1993-03-24 |
2000-01-27 |
Sanol Arznei Schwarz Gmbh |
Pharmazeutische Zusammensetzung in Form einer Packung
|
|
DK0678017T3
(da)
|
1993-11-05 |
1998-10-19 |
Amgen Inc |
Liposomfremstilling og materialeindkapslingsfremgangsmåde
|
|
RU2138293C1
(ru)
*
|
1993-12-15 |
1999-09-27 |
Бракко Рисерч С.А. |
Контрастные вещества для ультразвуковой эхографии, контрастные средства, содержащие эти вещества, и способы их приготовления
|
|
IT1269569B
(it)
*
|
1994-04-22 |
1997-04-08 |
Ugo Citernesi |
Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
|
|
US6156337A
(en)
*
|
1994-07-08 |
2000-12-05 |
Opperbas Holding B.V. |
Method for high loading of vesicles with biopolymeric substances
|
|
IL115099A
(en)
*
|
1994-10-14 |
1999-04-11 |
Upjohn Co |
Lyophilizate of phospholipid complex of water insoluble camptothecins
|
|
US5990077A
(en)
|
1995-04-14 |
1999-11-23 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
US5834428A
(en)
*
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
JP4148994B2
(ja)
|
1996-04-12 |
2008-09-10 |
１１４９３３６ オンタリオ インコーポレイテッド |
グルカゴン様ペプチド―２アナログ
|
|
US6111081A
(en)
*
|
1996-05-31 |
2000-08-29 |
Baylor College Of Medicine |
Lactoferrin variants and uses thereof
|
|
ES2278659T3
(es)
|
1996-10-25 |
2007-08-16 |
Monsanto Technology Llc |
Composicion y procedimiento para el tratamiento de plantas con productos quimicos exogenos.
|
|
EP0936860B1
(en)
*
|
1996-10-25 |
2002-02-20 |
Monsanto Technology LLC |
Composition and method for treating plants with exogenous chemicals
|
|
US6037125A
(en)
*
|
1996-11-05 |
2000-03-14 |
Lexicon Genetics Incorporated |
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
|
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
|
WO2002058622A2
(en)
*
|
2000-11-09 |
2002-08-01 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
|
ES2260321T3
(es)
*
|
2000-12-07 |
2006-11-01 |
Universiteit Utrecht Holding B.V. |
Composicion para el tratamiento de transtornos inflamatorios.
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
|
US6780324B2
(en)
*
|
2002-03-18 |
2004-08-24 |
Labopharm, Inc. |
Preparation of sterile stabilized nanodispersions
|
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
|
US20030212046A1
(en)
*
|
2002-05-07 |
2003-11-13 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20060093661A1
(en)
*
|
2002-05-07 |
2006-05-04 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
|
US20080045575A1
(en)
*
|
2004-12-29 |
2008-02-21 |
Van Dyke Thomas E |
Delivery of H2 Antagonists
|
|
BRPI0716890A2
(pt)
*
|
2006-09-22 |
2013-10-22 |
Labopharm Inc |
Composição, e, método de produção de uma composição, de administração de um agente farmaceuticamente ativo insolúvel em água a um mamífero, e de tratamento de câncer em um mamífero
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
EP2555791B1
(en)
|
2010-04-09 |
2017-11-01 |
Sinai Health System |
Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
|
|
CA2834968C
(en)
|
2011-01-05 |
2018-01-09 |
Livon Laboratories |
Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
|
|
EP3019188B1
(en)
|
2013-07-08 |
2022-03-09 |
The University of Utah Research Foundation |
A peptide and the use thereof in the treatment of inflammatory disorders
|
|
US10772926B2
(en)
|
2016-12-16 |
2020-09-15 |
Nutragen Health Innovations, Inc. |
Natural drugs for the treatment of inflammation and melanoma
|
|
WO2018204918A1
(en)
|
2017-05-05 |
2018-11-08 |
Ardelyx, Inc. |
Treatment of hepatic disorders
|
|
JP2021518401A
(ja)
|
2018-03-21 |
2021-08-02 |
コロラド ステート ユニバーシティー リサーチ ファウンデーション |
がんワクチン組成物及びその使用方法
|
|
RU2740553C2
(ru)
*
|
2019-01-30 |
2021-01-15 |
Анастасия Андреевна Карбаинова |
Способ получения липосомальной формы бетулина, обладающей гепатопротекторной активностью
|
|
LT6699B
(lt)
|
2019-07-15 |
2020-02-10 |
UAB "Valentis" |
Proliposomų gamybos būdas, naudojant ne daugiau kaip 5 % etanolio, ir jų panaudojimas lipofilinių medžiagų kapsuliavimui
|
|
CA3170563A1
(en)
|
2020-03-06 |
2021-09-10 |
Raymond P. Goodrich |
Production of vaccines comprising inactivated sars-cov-2 viral particles
|
|
IL300113A
(en)
|
2020-07-28 |
2023-03-01 |
Jazz Pharmaceuticals Ireland Ltd |
Compressed cyclic RAF inhibitors and methods of using them
|
|
KR20230058630A
(ko)
|
2020-07-28 |
2023-05-03 |
재즈 파마슈티칼즈 아일랜드 리미티드 |
융합된 바이사이클릭 raf 억제제의 키랄 합성
|
|
EP4312536A1
(en)
|
2021-04-01 |
2024-02-07 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
|
AU2022398450A1
(en)
|
2021-11-23 |
2024-06-06 |
Sail Biomedicines, Inc. |
A bacteria-derived lipid composition and use thereof
|
